Visceral fat cells, with their dense GH receptor population, respond particularly well
Targeting NOS1 either through Hsp90 inhibitors to block its mitochondrial localization or via specific inhibitors such as N-propyl-L-arginine may offer dual benefits: mitigating therapy resistance and addressing metabolic risk factors in CRC (57, 58)
Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence
The study reported lower risks for several cancers, including hepatocellular, colorectal, breast, and prostate cancers, though it did not find a significant reduction in lung cancer risk.25 So the honest answer is this: current human evidence does not show that NAC causes cancer, but animal and mechanistic research suggests NAC could behave differently depending on cancer type, disease stage, dose, and treatment context